Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Supplement 2002 (no. 46) to the Kauffmann-White scheme.

Popoff MY, Bockemühl J, Gheesling LL.

Res Microbiol. 2004 Sep;155(7):568-70.

PMID:
15313257
2.

Molecular analysis of the rfb O antigen gene cluster of Salmonella enterica serogroup O:6,14 and development of a serogroup-specific PCR assay.

Fitzgerald C, Sherwood R, Gheesling LL, Brenner FW, Fields PI.

Appl Environ Microbiol. 2003 Oct;69(10):6099-105.

3.

Supplement 2001 (no. 45) to the Kauffmann-White scheme.

Popoff MY, Bockemühl J, Gheesling LL.

Res Microbiol. 2003 Apr;154(3):173-4.

PMID:
12706505
4.

Supplement 2000 (no. 44) to the Kauffmann-White scheme.

Popoff MY, Bockemühl J, Brenner FW, Gheesling LL.

Res Microbiol. 2001 Dec;152(10):907-9.

PMID:
11766966
5.
6.

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Høiby EA, Holst J, Nøkleby H, Rosenqvist E, Sierra G, Campa C, Sotolongo F, Vega J, Garcia J, Herrera P, Poolman JT, Perkins BA.

JAMA. 1999 Apr 28;281(16):1520-7.

PMID:
10227322
7.

Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.

Maslanka SE, Tappero JW, Plikaytis BD, Brumberg RS, Dykes JK, Gheesling LL, Donaldson KB, Schuchat A, Pullman J, Jones M, Bushmaker J, Carlone GM.

Infect Immun. 1998 Jun;66(6):2453-9.

8.

Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease.

Raymond NJ, Reeves M, Ajello G, Baughman W, Gheesling LL, Carlone GM, Wenger JD, Stephens DS.

J Infect Dis. 1997 Nov;176(5):1277-84.

PMID:
9359729
9.

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Maslanka SE, Gheesling LL, Libutti DE, Donaldson KB, Harakeh HS, Dykes JK, Arhin FF, Devi SJ, Frasch CE, Huang JC, Kriz-Kuzemenska P, Lemmon RD, Lorange M, Peeters CC, Quataert S, Tai JY, Carlone GM.

Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67.

10.

Primary human immune response to Neisseria meningitidis serogroup C in interleukin-12-treated severe combined immunodeficient mice engrafted with human peripheral blood lymphocytes.

Westerink MA, Metzger DW, Hutchins WA, Adkins AR, Holder PF, Pais LB, Gheesling LL, Carlone GM.

J Infect Dis. 1997 Jan;175(1):84-90.

PMID:
8985200
11.

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.

Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI.

JAMA. 1996 May 15;275(19):1499-503.

PMID:
8622225
12.

Determination of parallelism and nonparallelism in bioassay dilution curves.

Plikaytis BD, Holder PF, Pais LB, Maslanka SE, Gheesling LL, Carlone GM.

J Clin Microbiol. 1994 Oct;32(10):2441-7.

13.

Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.

Gheesling LL, Carlone GM, Pais LB, Holder PF, Maslanka SE, Plikaytis BD, Achtman M, Densen P, Frasch CE, Käyhty H, et al.

J Clin Microbiol. 1994 Jun;32(6):1475-82.

14.

Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.

Ceesay SJ, Allen SJ, Menon A, Todd JE, Cham K, Carlone GM, Turner SH, Gheesling LL, DeWitt W, Plikaytis BD, et al.

J Infect Dis. 1993 May;167(5):1212-6.

PMID:
8486957
15.
16.

Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay.

Carlone GM, Frasch CE, Siber GR, Quataert S, Gheesling LL, Turner SH, Plikaytis BD, Helsel LO, DeWitt WE, Bibb WF, et al.

J Clin Microbiol. 1992 Jan;30(1):154-9.

17.
18.

Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group.

Carlone GM, Gorelkin L, Gheesling LL, Hoiseth SK, Mulks MH, O'Connor SP, Weyant RS, Myrick JE, Mayer LW, Arko RJ.

Pediatr Infect Dis J. 1989 Apr;8(4):245-7. No abstract available.

PMID:
2785676
19.

Potential virulence-associated factors in Brazilian purpuric fever. Brazilian Purpuric Fever Study Group.

Carlone GM, Gorelkin L, Gheesling LL, Erwin AL, Hoiseth SK, Mulks MH, O'Connor SP, Weyant RS, Myrick J, Rubin L, et al.

J Clin Microbiol. 1989 Apr;27(4):609-14. Review. No abstract available.

20.

Quality of commercially produced Shigella serogrouping and serotyping antisera.

Evins GM, Gheesling LL, Tauxe RV.

J Clin Microbiol. 1988 Mar;26(3):438-42.

Supplemental Content

Loading ...
Support Center